A detailed history of Black Rock Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,971,639 shares of PLRX stock, worth $61.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,971,639
Previous 4,655,385 6.79%
Holding current value
$61.3 Million
Previous $69.4 Million 22.95%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$10.58 - $15.61 $3.35 Million - $4.94 Million
316,254 Added 6.79%
4,971,639 $53.4 Million
Q1 2024

May 10, 2024

SELL
$14.14 - $19.59 $2.07 Million - $2.86 Million
-146,132 Reduced 3.04%
4,655,385 $69.4 Million
Q4 2023

Feb 13, 2024

BUY
$12.85 - $19.15 $6.15 Million - $9.17 Million
478,916 Added 11.08%
4,801,517 $87 Million
Q3 2023

Nov 13, 2023

SELL
$14.58 - $20.15 $1.23 Million - $1.7 Million
-84,219 Reduced 1.91%
4,322,601 $75 Million
Q2 2023

Aug 11, 2023

BUY
$18.12 - $30.56 $46.7 Million - $78.8 Million
2,578,692 Added 141.06%
4,406,820 $79.9 Million
Q1 2023

May 12, 2023

BUY
$18.73 - $36.26 $6.23 Million - $12.1 Million
332,626 Added 22.24%
1,828,128 $48.6 Million
Q4 2022

Feb 13, 2023

BUY
$17.0 - $25.43 $2.15 Million - $3.21 Million
126,382 Added 9.23%
1,495,502 $28.9 Million
Q3 2022

Nov 14, 2022

BUY
$7.67 - $24.23 $3.7 Million - $11.7 Million
483,034 Added 54.51%
1,369,120 $28.6 Million
Q2 2022

Aug 12, 2022

SELL
$4.11 - $8.75 $3.34 Million - $7.11 Million
-812,126 Reduced 47.82%
886,086 $7.1 Million
Q1 2022

May 12, 2022

BUY
$7.01 - $14.1 $72,469 - $145,765
10,338 Added 0.61%
1,698,212 $11.9 Million
Q4 2021

Feb 10, 2022

BUY
$12.27 - $18.26 $1.67 Million - $2.48 Million
135,882 Added 8.76%
1,687,874 $22.8 Million
Q3 2021

Nov 09, 2021

SELL
$16.48 - $28.98 $94,430 - $166,055
-5,730 Reduced 0.37%
1,551,992 $26.2 Million
Q2 2021

Aug 11, 2021

BUY
$28.05 - $37.69 $43.7 Million - $58.7 Million
1,557,722 New
1,557,722 $45.4 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.